China Suppliers > Nanjing CHICO pharmaceutical Co.,Ltd > (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
- Search Product
-
-
- Region :China/Jiangsu
- Tel : +86-13057662806
- Fax :
- Email :sales@chicopharm.com
- URL :www.chicopharm.com
- Add :No.9 Weidi Road—Jiangsu Life Science and Technology Innovation Park,Nanjing,China
- Details for (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
-
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
Category : Intermediates/Pharmaceutical intermediates
CAS NO : EC NO : MF : C29H33ClO10 MW : 577.02802 Specification : 99.0% Packing : 1KG Based on customer needs Product description : Please feel free to contact us for our stock position and price. Call us immediately to get the latest batch of COA and firm offer. The packaging method depends on the quantity and product property. We also offer a flexible packaging service as per customer’s requirement. Under normal circumstances, all quotations include domestic freight. Hereby we highlight some key messages for your information: 1.Quotation: Our quotation is usually valid for 2 to 4 weeks due to the market fluctuation. If you have any inquiry, please contact our sales managers. 2.Quality: We have established the finished products releasing procedure in order to regulate the analysis, examine and releasing management before product distribution, so as to ensure the products quality. 3.Order:Welcome to call and to place the order! Or you can follow us at the below accounts.~~~ Disclaimer:Products are only available to countries where there is no valid patent protection. Products still covered by patents rights are available exclusively for experimental or registration purpose pursuant to national applicable law, and shall be sold in strict accordance with the laws of the People's Republic of China and the laws of the Buyer's country. All products are not for human use. Buyer is obligated for evaluation of the patent situation in its domestic market and shall be held liable for uses which do not fall within the scope of the experimental or registration use exception and are not permitted by national applicable law. Uses : 461432-25-7 Synonyms : (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)-phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;(1S)-1,5-Anhydro-1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-D-Glucitol Tetraacetate;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-, tetraacetate, (1S)-;(2R,3S,4R,5S,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate;(2R,3R,4R,5S,6S)-2-(AcetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;Dapagliflozin Tetraacetate; Molecular Structure :
- more>>Other Products
-
- • Dasatinib monohydrate
- • Nilotinib monohydrochloride monohydrate
- • Ibrutinib
- • Erlotinib hydrochloride
- • Afatinib Dimaleate
- • Osimertinib mesylate
- • Ceritinib (LDK378)
- • Sorafenib tosylate
- • lenvatinib Mesylate
- • Vandetanib
- • Sunitinib Malate
- • Cabozantinib Malate
- • Pazopanib hydrochloride
- • Nintedanib
- • Palbociclib
- • Lapatinib ditosylate
- • Relugolix
- • Linagliptin